100 GENES FOUND

Show / hide columns »

XML | RDF | TAB | Page of 2 | next »

Gene

 

 

Gene description

x

 

 

Protein class

x

 

 

 

 

Tissue

Cell

Cancer

 

 

 

 

 

 

 

RNA tissue category

x

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

CACNA1ACalcium channel, voltage-dependent, P/Q type, alpha 1A subunitDisease related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
CACNA1BCalcium channel, voltage-dependent, N type, alpha 1B subunitDisease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Voltage-gated ion channels
Group enriched
CACNA1CCalcium channel, voltage-dependent, L type, alpha 1C subunitDisease related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
CACNA1DCalcium channel, voltage-dependent, L type, alpha 1D subunitCancer-related genes
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Voltage-gated ion channels
Mixed
CACNA1ECalcium channel, voltage-dependent, R type, alpha 1E subunitPredicted membrane proteins
Voltage-gated ion channels
Tissue enriched
CACNA1GCalcium channel, voltage-dependent, T type, alpha 1G subunitFDA approved drug targets
Plasma proteins
Predicted membrane proteins
Voltage-gated ion channels
Tissue enhanced
CACNA1HCalcium channel, voltage-dependent, T type, alpha 1H subunitDisease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
CACNA1SCalcium channel, voltage-dependent, L type, alpha 1S subunitDisease related genes
FDA approved drug targets
Predicted membrane proteins
Voltage-gated ion channels
Tissue enriched
CATSPER4Cation channel, sperm associated 4Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enriched
CNGA1Cyclic nucleotide gated channel alpha 1Disease related genes
Potential drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Mixed
CNGA2Cyclic nucleotide gated channel alpha 2Predicted membrane proteins
Voltage-gated ion channels
Not detected
CNGB3Cyclic nucleotide gated channel beta 3Disease related genes
Potential drug targets
Predicted intracellular proteins
Predicted membrane proteins
Voltage-gated ion channels
Tissue enhanced
HCN1Hyperpolarization activated cyclic nucleotide gated potassium channel 1Disease related genes
Plasma proteins
Potential drug targets
Predicted membrane proteins
Voltage-gated ion channels
Tissue enriched
HCN3Hyperpolarization activated cyclic nucleotide gated potassium channel 3Plasma proteins
Predicted membrane proteins
Voltage-gated ion channels
Mixed
KCNA1Potassium channel, voltage gated shaker related subfamily A, member 1Disease related genes
FDA approved drug targets
Predicted membrane proteins
Voltage-gated ion channels
Tissue enriched
KCNA10Potassium channel, voltage gated shaker related subfamily A, member 10FDA approved drug targets
Predicted membrane proteins
Voltage-gated ion channels
Tissue enhanced
KCNA2Potassium channel, voltage gated shaker related subfamily A, member 2Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enriched
KCNA3Potassium channel, voltage gated shaker related subfamily A, member 3FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Mixed
KCNA4Potassium channel, voltage gated shaker related subfamily A, member 4FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Voltage-gated ion channels
Tissue enhanced
KCNA5Potassium channel, voltage gated shaker related subfamily A, member 5Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNA6Potassium voltage-gated channel subfamily A member 6 FDA approved drug targets
Predicted membrane proteins
Voltage-gated ion channels
Not detected
KCNB1Potassium channel, voltage gated Shab related subfamily B, member 1Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNB2Potassium channel, voltage gated Shab related subfamily B, member 2FDA approved drug targets
Predicted membrane proteins
Voltage-gated ion channels
Tissue enhanced
KCNC1Potassium channel, voltage gated Shaw related subfamily C, member 1Disease related genes
FDA approved drug targets
Predicted membrane proteins
Voltage-gated ion channels
Tissue enriched
KCNC2Potassium channel, voltage gated Shaw related subfamily C, member 2FDA approved drug targets
Predicted membrane proteins
Voltage-gated ion channels
Tissue enriched
KCNC3Potassium channel, voltage gated Shaw related subfamily C, member 3Disease related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNC4Potassium channel, voltage gated Shaw related subfamily C, member 4Predicted membrane proteins
Voltage-gated ion channels
Mixed
KCND1Potassium channel, voltage gated Shal related subfamily D, member 1FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Voltage-gated ion channels
Mixed
KCND2Potassium channel, voltage gated Shal related subfamily D, member 2Disease related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCND3Potassium channel, voltage gated Shal related subfamily D, member 3Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Mixed
KCNF1Potassium channel, voltage gated modifier subfamily F, member 1Plasma proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enriched
KCNG1Potassium channel, voltage gated modifier subfamily G, member 1Predicted intracellular proteins
Predicted membrane proteins
Voltage-gated ion channels
Tissue enhanced
KCNG2Potassium channel, voltage gated modifier subfamily G, member 2Predicted membrane proteins
Voltage-gated ion channels
Not detected
KCNG3Potassium channel, voltage gated modifier subfamily G, member 3Predicted membrane proteins
Voltage-gated ion channels
Tissue enhanced
KCNG4Potassium channel, voltage gated modifier subfamily G, member 4Predicted membrane proteins
Voltage-gated ion channels
Not detected
KCNH1Potassium channel, voltage gated eag related subfamily H, member 1Disease related genes
Potential drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enriched
KCNH3Potassium channel, voltage gated eag related subfamily H, member 3Predicted membrane proteins
Transporters
Voltage-gated ion channels
Group enriched
KCNH5Potassium channel, voltage gated eag related subfamily H, member 5Predicted membrane proteins
Voltage-gated ion channels
Tissue enhanced
KCNH7Potassium channel, voltage gated eag related subfamily H, member 7Predicted membrane proteins
Voltage-gated ion channels
Tissue enriched
KCNJ1Potassium channel, inwardly rectifying subfamily J, member 1Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enriched
KCNJ11Potassium channel, inwardly rectifying subfamily J, member 11Disease related genes
FDA approved drug targets
Predicted membrane proteins
Voltage-gated ion channels
Tissue enhanced
KCNJ12Potassium channel, inwardly rectifying subfamily J, member 12FDA approved drug targets
Predicted membrane proteins
Voltage-gated ion channels
Group enriched
KCNJ14Potassium channel, inwardly rectifying subfamily J, member 14Predicted membrane proteins
Voltage-gated ion channels
Mixed
KCNJ15Potassium channel, inwardly rectifying subfamily J, member 15Predicted intracellular proteins
Predicted membrane proteins
Voltage-gated ion channels
Tissue enhanced
KCNJ16Potassium channel, inwardly rectifying subfamily J, member 16Predicted intracellular proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Group enriched
KCNJ2Potassium channel, inwardly rectifying subfamily J, member 2Disease related genes
Potential drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNJ3Potassium channel, inwardly rectifying subfamily J, member 3Plasma proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNJ5Potassium channel, inwardly rectifying subfamily J, member 5Cancer-related genes
Disease related genes
Potential drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNJ8Potassium channel, inwardly rectifying subfamily J, member 8Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Mixed
KCNJ9Potassium channel, inwardly rectifying subfamily J, member 9Predicted membrane proteins
Voltage-gated ion channels
Tissue enriched

Page of 2 | next »